Loading...
Efficacy and Safety of Capecitabine and Oxaliplatin (CapOX) as an Adjuvant Therapy in Japanese for Stage II/III Colon Cancer in a Group at High Risk of Recurrence in Retrospective Study
A number of large-scale clinical trials have demonstrated that using a combination of oxaliplatin and fluoropyrimidines as an adjuvant chemotherapy for stage II/III colon cancer improved the prognosis. However, there has only been experience in Japanese patients with using CapOX therapy, in which ca...
Saved in:
| Published in: | Oncol Res |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Cognizant Communication Corporation
2015
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7842523/ https://ncbi.nlm.nih.gov/pubmed/26629945 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3727/096504015X14410238486522 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|